Medical XpressOmega-3 Supplements May Be Linked to Faster Cognitive Decline in Seniors, Study Finds

ℹ️ Observational Association Only Evidence

A retrospective ADNI analysis of 273 omega-3 supplement users versus 546 matched non-users found faster cognitive decline over 5 years across MMSE, ADAS-Cog13, and CDR-SB. The signal persisted independent of APOE ε4 status and did not track with amyloid or tau accumulation.

Clinical Considerations

• Faster decline was observed across all three cognitive assessments, with groups matched for age, sex, genetics, and diagnosis.
• The association did not establish causality and was driven by observational data rather than a randomized trial.
• FDG-PET imaging showed reduced cerebral glucose metabolism in users, which the authors associate with possible synaptic dysfunction rather than classical AD proteinopathy.
• Findings diverge from prior animal and observational signals suggesting neuroprotection and align with controlled trials that have not shown cognitive benefit.

Practice Applications

• Interpret as hypothesis-generating; the finding warrants further investigation, not clinical action.
• Recognize that residual confounding remains likely despite propensity matching in an ADNI-enriched cohort.
• Avoid framing omega-3 supplementation as uniformly protective for cognition during patient counseling.
• Consider the absence of randomized evidence supporting omega-3 supplements for cognitive protection.